Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
Twist CJ, Schmidt ML, Naranjo A, London WB, Tenney SC, Marachelian A, Shimada H, Collins MH, Esiashvili N, Adkins ES, Mattei P, Handler M, Katzenstein H, Attiyeh E, Hogarty MD, Gastier-Foster J, Wagner E, Matthay KK, Park JR, Maris JM, Cohn SL. Twist CJ, et al. Among authors: katzenstein h. J Clin Oncol. 2019 Dec 1;37(34):3243-3255. doi: 10.1200/JCO.19.00919. Epub 2019 Aug 6. J Clin Oncol. 2019. PMID: 31386611 Free PMC article. Clinical Trial.
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, Look AT, Rowe ST, Nash MB, Holbrook T, Alvarado C, Rao PV, Castleberry RP, Cohn SL. Katzenstein HM, et al. J Clin Oncol. 1998 Jun;16(6):2007-17. doi: 10.1200/JCO.1998.16.6.2007. J Clin Oncol. 1998. PMID: 9626197
Angiogenesis in neuroblastoma.
Katzenstein HM, Cohn SL, Crawford S, Meitar D. Katzenstein HM, et al. J Clin Oncol. 2000 Jul;18(14):2789-91. doi: 10.1200/JCO.2000.18.14.2789. J Clin Oncol. 2000. PMID: 10894881 No abstract available.
Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM, Salwen HR, Nguyen NN, Meitar D, Cohn SL. Katzenstein HM, et al. Med Pediatr Oncol. 2001 Jan;36(1):190-3. doi: 10.1002/1096-911X(20010101)36:1<190::AID-MPO1045>3.0.CO;2-I. Med Pediatr Oncol. 2001. PMID: 11464880
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.
Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL. Kletzel M, et al. Among authors: katzenstein hm. J Clin Oncol. 2002 May 1;20(9):2284-92. doi: 10.1200/JCO.2002.06.060. J Clin Oncol. 2002. PMID: 11980999 Clinical Trial.
105 results